In The News Posted February 21, 2019 Share Posted February 21, 2019 SAN FRANCISCO, Feb. 21, 2019 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2018, on Thursday, February 28, 2019, after the close of U.S.-based financial markets. Howard Robin, President and Chief... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.